Peregrine Asset Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,366	Closed	-$228K	–	107
2015 Q4	$228K	Buy	+3,366	New	+$228K	0.2%	78
2015 Q3	–	Sell	-3,366	Closed	-$212K	–	100
2015 Q2	$212K	Buy	+3,366	New	+$212K	0.16%	99